StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.75+0.01 (+0.57%)

Close on Nov 18, 2026Market cap $21.95MP/E –Yield –

Incannex Healthcare operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Incannex Healthcare's operating income for the twelve months ending Sep 30, 2026 was -$19.67M. For fiscal 2026 it was -$23.03M.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$23.03M–
FY2025Jun 30, 2025-$23.79M–
FY2024Jun 30, 2024-$30.04M–
FY2023Jun 30, 2023-$49.67M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$3.44M–
Q4 FY2026CQ2 2026Jun 30, 2026-$5.19M–
Q3 FY2026CQ1 2026Mar 31, 2026-$4.05M–
Q2 FY2026CQ4 2025Dec 31, 2025-$7.00M–
Q1 FY2026CQ3 2025Sep 30, 2025-$6.79M–
Q4 FY2025CQ2 2025Jun 30, 2025-$7.53M–
Q3 FY2025CQ1 2025Mar 31, 2025-$5.00M–
Q2 FY2025CQ4 2024Dec 31, 2024-$5.00M–
Q1 FY2025CQ3 2024Sep 30, 2024-$6.25M–
Q4 FY2024CQ2 2024Jun 30, 2024-$9.74M–
Q3 FY2024CQ1 2024Mar 31, 2024-$7.42M–
Q2 FY2024CQ4 2023Dec 31, 2023-$7.98M–
Q1 FY2024CQ3 2023Sep 30, 2023-$4.89M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.19M–
Q3 FY2023CQ1 2023Mar 31, 2023-$3.65M–
Q2 FY2023CQ4 2022Dec 31, 2022-$3.64M–

More Incannex Healthcare figures

See a number that looks wrong?